In Vivo Preoperative Skin Preparation Persistence Evaluation

• Status: Completed
• Trial end date: 2017-04-25
• Target enrollment: 0
• Participant gender: All

Summary

Evaluate persistent antimicrobial effectiveness of chlorhexidine gluconate containing products on abdominal and inguinal sites following a saline and wipe challenge.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: 3M
• Treatments: Chlorhexidine; Chlorhexidine gluconate; Ethanol

Criteria

Inclusion Criteria:

• Subjects of any race

• Subjects in good health

• Minimum skin flora baseline requirements on abdomen and groin

Exclusion Criteria:

• Any tattoos, scars, breaks in the skin, or any form of dermatitis, or other skin disorders (including acne) on the applicable test area

• Topical antimicrobial exposure within 14 days prior to screening and treatment days

• Use of systemic or topical antibiotics, steroid medications, or any other products known to affect the normal microbial flora of the skin within 14 days prior to screening and treatment days